[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Spine Surgery Biologics Supply, Demand and Key Producers, 2023-2029

March 2023 | 110 pages | ID: G9245CC21C85EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Spine Surgery Biologics market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Spinal fusion products are used in spinal fusion surgery. The products are involved in removing the damaged disc and replacing it with any fusion products.

This report studies the global Spine Surgery Biologics demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Spine Surgery Biologics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Spine Surgery Biologics that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Spine Surgery Biologics total market, 2018-2029, (USD Million)

Global Spine Surgery Biologics total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Spine Surgery Biologics total market, key domestic companies and share, (USD Million)

Global Spine Surgery Biologics revenue by player and market share 2018-2023, (USD Million)

Global Spine Surgery Biologics total market by Type, CAGR, 2018-2029, (USD Million)

Global Spine Surgery Biologics total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Spine Surgery Biologics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Medtronic, J & J, Stryker Corporation, Nuvasive, Zimmer Biomet, Orthofix International, Globus Medical, alphatec spine and K2M, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Spine Surgery Biologics market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Spine Surgery Biologics Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Spine Surgery Biologics Market, Segmentation by Type
  • Bone Graft
  • Bone Graft Substitute
  • Platelet Rich Plasma (PRP)
  • Other
Global Spine Surgery Biologics Market, Segmentation by Application
  • Open Surgery
  • Minimally Invasive Surgery
Companies Profiled:
  • Medtronic
  • J & J
  • Stryker Corporation
  • Nuvasive
  • Zimmer Biomet
  • Orthofix International
  • Globus Medical
  • alphatec spine
  • K2M
  • Exactech
  • Wright Medical Technology
  • X-Spine
  • Nutech
  • Arthrex
Key Questions Answered

1. How big is the global Spine Surgery Biologics market?

2. What is the demand of the global Spine Surgery Biologics market?

3. What is the year over year growth of the global Spine Surgery Biologics market?

4. What is the total value of the global Spine Surgery Biologics market?

5. Who are the major players in the global Spine Surgery Biologics market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Spine Surgery Biologics Introduction
1.2 World Spine Surgery Biologics Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Spine Surgery Biologics Total Market by Region (by Headquarter Location)
  1.3.1 World Spine Surgery Biologics Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Spine Surgery Biologics Market Size (2018-2029)
  1.3.3 China Spine Surgery Biologics Market Size (2018-2029)
  1.3.4 Europe Spine Surgery Biologics Market Size (2018-2029)
  1.3.5 Japan Spine Surgery Biologics Market Size (2018-2029)
  1.3.6 South Korea Spine Surgery Biologics Market Size (2018-2029)
  1.3.7 ASEAN Spine Surgery Biologics Market Size (2018-2029)
  1.3.8 India Spine Surgery Biologics Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Spine Surgery Biologics Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Spine Surgery Biologics Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Spine Surgery Biologics Consumption Value (2018-2029)
2.2 World Spine Surgery Biologics Consumption Value by Region
  2.2.1 World Spine Surgery Biologics Consumption Value by Region (2018-2023)
  2.2.2 World Spine Surgery Biologics Consumption Value Forecast by Region (2024-2029)
2.3 United States Spine Surgery Biologics Consumption Value (2018-2029)
2.4 China Spine Surgery Biologics Consumption Value (2018-2029)
2.5 Europe Spine Surgery Biologics Consumption Value (2018-2029)
2.6 Japan Spine Surgery Biologics Consumption Value (2018-2029)
2.7 South Korea Spine Surgery Biologics Consumption Value (2018-2029)
2.8 ASEAN Spine Surgery Biologics Consumption Value (2018-2029)
2.9 India Spine Surgery Biologics Consumption Value (2018-2029)

3 WORLD SPINE SURGERY BIOLOGICS COMPANIES COMPETITIVE ANALYSIS

3.1 World Spine Surgery Biologics Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Spine Surgery Biologics Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Spine Surgery Biologics in 2022
  3.2.3 Global Concentration Ratios (CR8) for Spine Surgery Biologics in 2022
3.3 Spine Surgery Biologics Company Evaluation Quadrant
3.4 Spine Surgery Biologics Market: Overall Company Footprint Analysis
  3.4.1 Spine Surgery Biologics Market: Region Footprint
  3.4.2 Spine Surgery Biologics Market: Company Product Type Footprint
  3.4.3 Spine Surgery Biologics Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Spine Surgery Biologics Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Spine Surgery Biologics Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Spine Surgery Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Spine Surgery Biologics Consumption Value Comparison
  4.2.1 United States VS China: Spine Surgery Biologics Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Spine Surgery Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Spine Surgery Biologics Companies and Market Share, 2018-2023
  4.3.1 United States Based Spine Surgery Biologics Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Spine Surgery Biologics Revenue, (2018-2023)
4.4 China Based Companies Spine Surgery Biologics Revenue and Market Share, 2018-2023
  4.4.1 China Based Spine Surgery Biologics Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Spine Surgery Biologics Revenue, (2018-2023)
4.5 Rest of World Based Spine Surgery Biologics Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Spine Surgery Biologics Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Spine Surgery Biologics Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Spine Surgery Biologics Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Bone Graft
  5.2.2 Bone Graft Substitute
  5.2.3 Platelet Rich Plasma (PRP)
  5.2.4 Other
5.3 Market Segment by Type
  5.3.1 World Spine Surgery Biologics Market Size by Type (2018-2023)
  5.3.2 World Spine Surgery Biologics Market Size by Type (2024-2029)
  5.3.3 World Spine Surgery Biologics Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Spine Surgery Biologics Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Open Surgery
  6.2.2 Minimally Invasive Surgery
6.3 Market Segment by Application
  6.3.1 World Spine Surgery Biologics Market Size by Application (2018-2023)
  6.3.2 World Spine Surgery Biologics Market Size by Application (2024-2029)
  6.3.3 World Spine Surgery Biologics Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Medtronic
  7.1.1 Medtronic Details
  7.1.2 Medtronic Major Business
  7.1.3 Medtronic Spine Surgery Biologics Product and Services
  7.1.4 Medtronic Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Medtronic Recent Developments/Updates
  7.1.6 Medtronic Competitive Strengths & Weaknesses
7.2 J & J
  7.2.1 J & J Details
  7.2.2 J & J Major Business
  7.2.3 J & J Spine Surgery Biologics Product and Services
  7.2.4 J & J Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 J & J Recent Developments/Updates
  7.2.6 J & J Competitive Strengths & Weaknesses
7.3 Stryker Corporation
  7.3.1 Stryker Corporation Details
  7.3.2 Stryker Corporation Major Business
  7.3.3 Stryker Corporation Spine Surgery Biologics Product and Services
  7.3.4 Stryker Corporation Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Stryker Corporation Recent Developments/Updates
  7.3.6 Stryker Corporation Competitive Strengths & Weaknesses
7.4 Nuvasive
  7.4.1 Nuvasive Details
  7.4.2 Nuvasive Major Business
  7.4.3 Nuvasive Spine Surgery Biologics Product and Services
  7.4.4 Nuvasive Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Nuvasive Recent Developments/Updates
  7.4.6 Nuvasive Competitive Strengths & Weaknesses
7.5 Zimmer Biomet
  7.5.1 Zimmer Biomet Details
  7.5.2 Zimmer Biomet Major Business
  7.5.3 Zimmer Biomet Spine Surgery Biologics Product and Services
  7.5.4 Zimmer Biomet Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Zimmer Biomet Recent Developments/Updates
  7.5.6 Zimmer Biomet Competitive Strengths & Weaknesses
7.6 Orthofix International
  7.6.1 Orthofix International Details
  7.6.2 Orthofix International Major Business
  7.6.3 Orthofix International Spine Surgery Biologics Product and Services
  7.6.4 Orthofix International Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Orthofix International Recent Developments/Updates
  7.6.6 Orthofix International Competitive Strengths & Weaknesses
7.7 Globus Medical
  7.7.1 Globus Medical Details
  7.7.2 Globus Medical Major Business
  7.7.3 Globus Medical Spine Surgery Biologics Product and Services
  7.7.4 Globus Medical Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 Globus Medical Recent Developments/Updates
  7.7.6 Globus Medical Competitive Strengths & Weaknesses
7.8 alphatec spine
  7.8.1 alphatec spine Details
  7.8.2 alphatec spine Major Business
  7.8.3 alphatec spine Spine Surgery Biologics Product and Services
  7.8.4 alphatec spine Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 alphatec spine Recent Developments/Updates
  7.8.6 alphatec spine Competitive Strengths & Weaknesses
7.9 K2M
  7.9.1 K2M Details
  7.9.2 K2M Major Business
  7.9.3 K2M Spine Surgery Biologics Product and Services
  7.9.4 K2M Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 K2M Recent Developments/Updates
  7.9.6 K2M Competitive Strengths & Weaknesses
7.10 Exactech
  7.10.1 Exactech Details
  7.10.2 Exactech Major Business
  7.10.3 Exactech Spine Surgery Biologics Product and Services
  7.10.4 Exactech Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 Exactech Recent Developments/Updates
  7.10.6 Exactech Competitive Strengths & Weaknesses
7.11 Wright Medical Technology
  7.11.1 Wright Medical Technology Details
  7.11.2 Wright Medical Technology Major Business
  7.11.3 Wright Medical Technology Spine Surgery Biologics Product and Services
  7.11.4 Wright Medical Technology Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Wright Medical Technology Recent Developments/Updates
  7.11.6 Wright Medical Technology Competitive Strengths & Weaknesses
7.12 X-Spine
  7.12.1 X-Spine Details
  7.12.2 X-Spine Major Business
  7.12.3 X-Spine Spine Surgery Biologics Product and Services
  7.12.4 X-Spine Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 X-Spine Recent Developments/Updates
  7.12.6 X-Spine Competitive Strengths & Weaknesses
7.13 Nutech
  7.13.1 Nutech Details
  7.13.2 Nutech Major Business
  7.13.3 Nutech Spine Surgery Biologics Product and Services
  7.13.4 Nutech Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Nutech Recent Developments/Updates
  7.13.6 Nutech Competitive Strengths & Weaknesses
7.14 Arthrex
  7.14.1 Arthrex Details
  7.14.2 Arthrex Major Business
  7.14.3 Arthrex Spine Surgery Biologics Product and Services
  7.14.4 Arthrex Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Arthrex Recent Developments/Updates
  7.14.6 Arthrex Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Spine Surgery Biologics Industry Chain
8.2 Spine Surgery Biologics Upstream Analysis
8.3 Spine Surgery Biologics Midstream Analysis
8.4 Spine Surgery Biologics Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Spine Surgery Biologics Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Spine Surgery Biologics Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Spine Surgery Biologics Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Spine Surgery Biologics Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Spine Surgery Biologics Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Spine Surgery Biologics Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Spine Surgery Biologics Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Spine Surgery Biologics Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Spine Surgery Biologics Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Spine Surgery Biologics Players in 2022
Table 12. World Spine Surgery Biologics Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Spine Surgery Biologics Company Evaluation Quadrant
Table 14. Head Office of Key Spine Surgery Biologics Player
Table 15. Spine Surgery Biologics Market: Company Product Type Footprint
Table 16. Spine Surgery Biologics Market: Company Product Application Footprint
Table 17. Spine Surgery Biologics Mergers & Acquisitions Activity
Table 18. United States VS China Spine Surgery Biologics Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Spine Surgery Biologics Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Spine Surgery Biologics Companies, Headquarters (States, Country)
Table 21. United States Based Companies Spine Surgery Biologics Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Spine Surgery Biologics Revenue Market Share (2018-2023)
Table 23. China Based Spine Surgery Biologics Companies, Headquarters (Province, Country)
Table 24. China Based Companies Spine Surgery Biologics Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Spine Surgery Biologics Revenue Market Share (2018-2023)
Table 26. Rest of World Based Spine Surgery Biologics Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Spine Surgery Biologics Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Spine Surgery Biologics Revenue Market Share (2018-2023)
Table 29. World Spine Surgery Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Spine Surgery Biologics Market Size by Type (2018-2023) & (USD Million)
Table 31. World Spine Surgery Biologics Market Size by Type (2024-2029) & (USD Million)
Table 32. World Spine Surgery Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Spine Surgery Biologics Market Size by Application (2018-2023) & (USD Million)
Table 34. World Spine Surgery Biologics Market Size by Application (2024-2029) & (USD Million)
Table 35. Medtronic Basic Information, Area Served and Competitors
Table 36. Medtronic Major Business
Table 37. Medtronic Spine Surgery Biologics Product and Services
Table 38. Medtronic Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Medtronic Recent Developments/Updates
Table 40. Medtronic Competitive Strengths & Weaknesses
Table 41. J & J Basic Information, Area Served and Competitors
Table 42. J & J Major Business
Table 43. J & J Spine Surgery Biologics Product and Services
Table 44. J & J Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. J & J Recent Developments/Updates
Table 46. J & J Competitive Strengths & Weaknesses
Table 47. Stryker Corporation Basic Information, Area Served and Competitors
Table 48. Stryker Corporation Major Business
Table 49. Stryker Corporation Spine Surgery Biologics Product and Services
Table 50. Stryker Corporation Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Stryker Corporation Recent Developments/Updates
Table 52. Stryker Corporation Competitive Strengths & Weaknesses
Table 53. Nuvasive Basic Information, Area Served and Competitors
Table 54. Nuvasive Major Business
Table 55. Nuvasive Spine Surgery Biologics Product and Services
Table 56. Nuvasive Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Nuvasive Recent Developments/Updates
Table 58. Nuvasive Competitive Strengths & Weaknesses
Table 59. Zimmer Biomet Basic Information, Area Served and Competitors
Table 60. Zimmer Biomet Major Business
Table 61. Zimmer Biomet Spine Surgery Biologics Product and Services
Table 62. Zimmer Biomet Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Zimmer Biomet Recent Developments/Updates
Table 64. Zimmer Biomet Competitive Strengths & Weaknesses
Table 65. Orthofix International Basic Information, Area Served and Competitors
Table 66. Orthofix International Major Business
Table 67. Orthofix International Spine Surgery Biologics Product and Services
Table 68. Orthofix International Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Orthofix International Recent Developments/Updates
Table 70. Orthofix International Competitive Strengths & Weaknesses
Table 71. Globus Medical Basic Information, Area Served and Competitors
Table 72. Globus Medical Major Business
Table 73. Globus Medical Spine Surgery Biologics Product and Services
Table 74. Globus Medical Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Globus Medical Recent Developments/Updates
Table 76. Globus Medical Competitive Strengths & Weaknesses
Table 77. alphatec spine Basic Information, Area Served and Competitors
Table 78. alphatec spine Major Business
Table 79. alphatec spine Spine Surgery Biologics Product and Services
Table 80. alphatec spine Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. alphatec spine Recent Developments/Updates
Table 82. alphatec spine Competitive Strengths & Weaknesses
Table 83. K2M Basic Information, Area Served and Competitors
Table 84. K2M Major Business
Table 85. K2M Spine Surgery Biologics Product and Services
Table 86. K2M Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. K2M Recent Developments/Updates
Table 88. K2M Competitive Strengths & Weaknesses
Table 89. Exactech Basic Information, Area Served and Competitors
Table 90. Exactech Major Business
Table 91. Exactech Spine Surgery Biologics Product and Services
Table 92. Exactech Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Exactech Recent Developments/Updates
Table 94. Exactech Competitive Strengths & Weaknesses
Table 95. Wright Medical Technology Basic Information, Area Served and Competitors
Table 96. Wright Medical Technology Major Business
Table 97. Wright Medical Technology Spine Surgery Biologics Product and Services
Table 98. Wright Medical Technology Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Wright Medical Technology Recent Developments/Updates
Table 100. Wright Medical Technology Competitive Strengths & Weaknesses
Table 101. X-Spine Basic Information, Area Served and Competitors
Table 102. X-Spine Major Business
Table 103. X-Spine Spine Surgery Biologics Product and Services
Table 104. X-Spine Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. X-Spine Recent Developments/Updates
Table 106. X-Spine Competitive Strengths & Weaknesses
Table 107. Nutech Basic Information, Area Served and Competitors
Table 108. Nutech Major Business
Table 109. Nutech Spine Surgery Biologics Product and Services
Table 110. Nutech Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Nutech Recent Developments/Updates
Table 112. Arthrex Basic Information, Area Served and Competitors
Table 113. Arthrex Major Business
Table 114. Arthrex Spine Surgery Biologics Product and Services
Table 115. Arthrex Spine Surgery Biologics Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 116. Global Key Players of Spine Surgery Biologics Upstream (Raw Materials)
Table 117. Spine Surgery Biologics Typical Customers

LIST OF FIGURES

Figure 1. Spine Surgery Biologics Picture
Figure 2. World Spine Surgery Biologics Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Spine Surgery Biologics Total Market Size (2018-2029) & (USD Million)
Figure 4. World Spine Surgery Biologics Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Spine Surgery Biologics Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Spine Surgery Biologics Revenue (2018-2029) & (USD Million)
Figure 13. Spine Surgery Biologics Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 16. World Spine Surgery Biologics Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 18. China Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 23. India Spine Surgery Biologics Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Spine Surgery Biologics by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Spine Surgery Biologics Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Spine Surgery Biologics Markets in 2022
Figure 27. United States VS China: Spine Surgery Biologics Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Spine Surgery Biologics Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Spine Surgery Biologics Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Spine Surgery Biologics Market Size Market Share by Type in 2022
Figure 31. Bone Graft
Figure 32. Bone Graft Substitute
Figure 33. Platelet Rich Plasma (PRP)
Figure 34. Other
Figure 35. World Spine Surgery Biologics Market Size Market Share by Type (2018-2029)
Figure 36. World Spine Surgery Biologics Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Spine Surgery Biologics Market Size Market Share by Application in 2022
Figure 38. Open Surgery
Figure 39. Minimally Invasive Surgery
Figure 40. Spine Surgery Biologics Industrial Chain
Figure 41. Methodology
Figure 42. Research Process and Data Source


More Publications